Status:
UNKNOWN
Lung Cancer and Idiopathic Pulmonary Fibrosis : Pathological and Molecular Characterization
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Lung Cancer and Idiopathic Pulmonary Fibrosis
Eligibility:
All Genders
18+ years
Brief Summary
Retrospective inclusion of lung cancers developed in a context of idiopathic pulmonary fibrosis, diagnosed and / or treated in participating centers. The cases are recovered retrospectively from the r...
Detailed Description
Primary objective: Characterize altered molecular pathways in lung cancer in patients with IPF versus lung cancer in non-IPF patients. Secondary objectives: Identify specific therapeutic targets De...
Eligibility Criteria
Inclusion
- Lung carcinoma
- Idiopathic pulmonary fibrosis
Exclusion
- \- No tumor sample available
Key Trial Info
Start Date :
February 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2020
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03486262
Start Date
February 1 2018
End Date
February 1 2020
Last Update
October 11 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hopital BICHAT-CLAUDE BERNARD
Paris, France, 75018